Fig 2E shows also the effect of anti-PD-1 on tumor treated with anti-TGF-β: In the first few weeks, tumor volume slightly increases (hyperprogression of cancer) but later on it decreases, and by day 45 it is significantly decreased under the combined therapy. This evidence concerns the gene TGFB1 and cancer.